Abstract
The article considers the efficiency of using a new therapeutic approach in the therapy of secondary osteoarthritis in patients with rheumatoid arthritis. The dynamics of the Cartilage Oligomeric Matrix Protein, the activity of the disease based on DAS28, and the cytokine profile are estimated. Analysis of the results showed the advantages of using the interleukin-1 inhibitor in a complex with laser therapy in the treatment of secondary osteoarthritis in patients with rheumatoid arthritis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
